Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gaillard

Showing results (191-200 of 426) with videos related to

Pageof 43
Sort By:
Animal Genetics|February 1, 1995
Features of the DNA fingerprinting probe pITZ1K J Huebscher, G Dolf, J Frey, et al.
Neuroendocrinology|January 15, 2009
Prolonged but not short negative energy condition restored corticoadrenal leptin sensitivity in the hypothalamic obese ratMario Perello, Daniel Castrogiovanni, Andrés Giovambattista, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1992
Immunohistochemical detection of proluteinizing hormone-releasing hormone peptides in neurons in the human hypothalamusB Bloch, R C Gaillard, M D Culler, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1990
Stimulation of growth hormone release in man by the potent D2-dopamine agonist CV 205-502: comparison of responses to intravenous and oral administrationJ P Miell, F P Pralong, R Corder, et al.
Neuroendocrinology|October 1, 1995
Repeated endotoxin treatment decreases immune and hypothalamo-pituitary-adrenal axis responses: effects of orchidectomy and testosterone therapyR Hadid, E Spinedi, T Daneva, et al.
British Journal of Clinical Pharmacology|July 1, 1986
Description of the time course of the prolactin suppressant effect of the dopamine agonist CQP201-403 by an integrated pharmacokinetic-pharmacodynamic modelJ Grevel, J Brownell, J L Steimer, et al.
The Journal of Endocrinology|October 1, 1991
Effects of glucocorticoid treatment and acute passive immunization with growth hormone-releasing hormone and somatostatin antibodies on endogenous and stimulated growth hormone secretion in the male ratJ Miell, R Corder, P J Miell, et al.
Neuroendocrinology|May 27, 1999
Role of glucocorticoids in the response of the hypothalamo-corticotrope, immune and adipose systems to repeated endotoxin administrationT Chautard, E Spinedi, M Voirol, et al.
Regulatory Peptides|November 4, 2000
Acceleration of pubertal development following central blockade of the Y1 subtype of neuropeptide Y receptorsF P Pralong, M Voirol, M Giacomini, et al.
Cytokine|June 14, 2000
Differences in the genotypes and plasma concentrations of the INTERLEUKIN-1 receptor antagonist in black and white South African asthmatics and control subjectsV Pillay, M C Gaillard, A Halkas, et al.
Pageof 43

Showing results (191-200 of 426) with videos related to

Sort By:
Pageof 43
Animal Genetics|February 1, 1995
Features of the DNA fingerprinting probe pITZ1K J Huebscher, G Dolf, J Frey, et al.
Neuroendocrinology|January 15, 2009
Prolonged but not short negative energy condition restored corticoadrenal leptin sensitivity in the hypothalamic obese ratMario Perello, Daniel Castrogiovanni, Andrés Giovambattista, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1992
Immunohistochemical detection of proluteinizing hormone-releasing hormone peptides in neurons in the human hypothalamusB Bloch, R C Gaillard, M D Culler, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1990
Stimulation of growth hormone release in man by the potent D2-dopamine agonist CV 205-502: comparison of responses to intravenous and oral administrationJ P Miell, F P Pralong, R Corder, et al.
Neuroendocrinology|October 1, 1995
Repeated endotoxin treatment decreases immune and hypothalamo-pituitary-adrenal axis responses: effects of orchidectomy and testosterone therapyR Hadid, E Spinedi, T Daneva, et al.
British Journal of Clinical Pharmacology|July 1, 1986
Description of the time course of the prolactin suppressant effect of the dopamine agonist CQP201-403 by an integrated pharmacokinetic-pharmacodynamic modelJ Grevel, J Brownell, J L Steimer, et al.
The Journal of Endocrinology|October 1, 1991
Effects of glucocorticoid treatment and acute passive immunization with growth hormone-releasing hormone and somatostatin antibodies on endogenous and stimulated growth hormone secretion in the male ratJ Miell, R Corder, P J Miell, et al.
Neuroendocrinology|May 27, 1999
Role of glucocorticoids in the response of the hypothalamo-corticotrope, immune and adipose systems to repeated endotoxin administrationT Chautard, E Spinedi, M Voirol, et al.
Regulatory Peptides|November 4, 2000
Acceleration of pubertal development following central blockade of the Y1 subtype of neuropeptide Y receptorsF P Pralong, M Voirol, M Giacomini, et al.
Cytokine|June 14, 2000
Differences in the genotypes and plasma concentrations of the INTERLEUKIN-1 receptor antagonist in black and white South African asthmatics and control subjectsV Pillay, M C Gaillard, A Halkas, et al.
Pageof 43